Form 4: Biogen Executive Adam Keeney Reports Stock Transactions
SEC Form 4 Filing
Adam Keeney, Head of Corporate Development at Biogen, reports the vesting and subsequent disposal of restricted stock units.
Summary
- On May 1, 2024, Adam Keeney, Head of Corporate Development at Biogen, reported transactions involving Biogen common stock.
- These transactions included the vesting of 938 restricted stock units and the disposal of 276 shares to cover tax obligations.
- Following these transactions, Keeney directly owns 662 shares of Biogen common stock and 1,877 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral filing, simply reporting required stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- Similar filings are made by executives at comparable companies like Amgen (AMGN) and Gilead Sciences (GILD) when they trade their company's stock.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine stock activity by an executive.
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 05/01/2023 | Grant date of the restricted stock units, which vest in three equal yearly installments beginning on the first anniversary. |
| 05/01/2024 | Date of the reported transactions: vesting of restricted stock units and disposal of shares for tax obligations. |
| 05/01/2026 | Expiration date of the restricted stock units. |
| 05/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.